Trials / Completed
CompletedNCT01812733
Non-interventional Study Comparing Targiniq and Oxycodone/Laxatives
An Observational Study of Quality of Life, Resource Use and Costs Associated With Treatment of Severe Pain - a Comparison of a Combination of Oxycodone and Naloxone (Targiniq) Versus Oxycodone and Laxatives
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 37 (actual)
- Sponsor
- Mundipharma AB · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the non-interventional study is to compare the quality of life, health care resource use and costs between the use of a combination of oxycodone and naloxone (Targiniq) versus oxycodone and laxatives for patients with severe pain, and to evaluate the cost-effectiveness of treatment with Targiniq.
Conditions
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2013-03-18
- Last updated
- 2015-08-07
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01812733. Inclusion in this directory is not an endorsement.